Inflammatix
About Inflammatix
Inflammatix is a pioneering molecular diagnostics company that leverages artificial intelligence and machine learning to interpret the body’s immune response for the rapid diagnosis of acute infections and assessment of illness severity. The company’s core technology involves measuring specific messenger RNA markers in blood samples to provide insights into whether an infection is bacterial or viral, and to gauge the overall severity of the patient’s condition. This approach aims to provide physicians with timely, data-driven insights to make confident clinical decisions, particularly in emergency department settings, thereby improving patient management and outcomes for critical conditions like sepsis and pneumonia.
The company’s lead product, the TriVerity™ Acute Infection and Sepsis Test, is designed to run on its proprietary Myrna™ Instrument, a cartridge-based benchtop analyzer, delivering results in approximately 30 minutes. This rapid, host-response-based diagnostic system is intended to aid in the early detection and differentiation of acute infections and sepsis, which are major public health challenges. By providing clarity on infection type and illness severity, Inflammatix seeks to enable precision medicine at the point of care, optimize antimicrobial therapy selection, guide further diagnostic testing, and inform patient admission or discharge decisions.
Focus Areas
Business Intelligence
| Key Investors | Khosla Ventures, Think.Health, Northpond Ventures, D1 Capital Partners, Iberis Capital, Vesalius BioCapital, OSF Healthcare, RAW Ventures, Stanford-StartX Fund, Defense Advanced Research Projects Agency (DARPA), National Institutes of Health (NIH), Biomedical Advanced Research and Development Authority (BARDA) |
| Partnerships | Veranex (Myrna Instrument design/manufacture), Acutelines (University Medical College Groningen for sepsis diagnosis), NIH, DRIVe, BARDA, DARPA (funding/support), SUBSPACE Consortium (research) |
| Technology | Host-response diagnostics, Molecular diagnostics, Gene expression analysis, Machine learning-derived algorithms, AI-powered immune profiling, Proprietary Myrna™ Instrument, Sample-to-answer isothermal instrument platform |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Inflammatix's TriVerityu2122 Test System offers rapid, actionable insights within approximately 30 minutes, which is crucial for acute care settings like the Emergency Department. It provides three key scores: the likelihood of bacterial infection, viral infection, and overall illness severity. This allows for confident decision-making regarding antibiotic prescription, the necessity of further diagnostic testing, and appropriate patient disposition (e.g., admission or discharge). By focusing on the host immune response rather than solely pathogen detection, it addresses the limitations of traditional diagnostics, especially when pathogens are not present in the bloodstream. Clinical studies have shown superior analytical performance and accuracy compared to standard of care, potentially leading to improved patient outcomes, reduced hospital stays, and decreased antibiotic use.
Inflammatix's diagnostic tests, including TriVerityu2122, are designed to run on their proprietary Myrnau2122 Instrument, a cartridge-based, benchtop, sample-to-answer analyzer. This indicates a self-contained system for their diagnostics. The company also leverages cloud infrastructure, specifically AWS, for its operations. They engage in collaborations with military and healthcare institutions for clinical study design and execution.
What the Web Says
Inflammatix appears to be a company in the healthcare or biotech sector, likely focusing on diagnostics or therapeutics related to inflammation. Information regarding specific product reviews or detailed employer opinions from the requested sources (G2, Glassdoor, Capterra, Reddit) is limited or not readily available through a quick web search, suggesting it might be a smaller, newer, or more specialized company without a broad public review footprint on these platforms. Therefore, a comprehensive review based solely on these sources is challenging.
Overall: MixedStrengths
- Unknown - insufficient public reviews available on specified platforms.
- Potential for innovation in inflammation-related healthcare (inferred from name).
- Likely specialized focus within the medical field.
Limitations
- Lack of readily available public product reviews on G2 or Capterra.
- Limited employer reviews on Glassdoor, making company culture assessment difficult.
- No significant discussion or reviews found on Reddit.
- Difficulty in assessing product effectiveness or user satisfaction due to lack of data.
- Unknown company size or market penetration based on review availability.
Based on reviews from: G2 (no specific reviews found), Glassdoor (no specific reviews found), Capterra (no specific reviews found), Reddit (no specific discussions found), General web search for 'Inflammatix reviews'
Last updated: 2026-07-18
Videos
News, demos, and interviews about Inflammatix.
Videos load interactively. If none appear, search YouTube for Inflammatix →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Inflammatix.
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]